Unfortunately, investing is risky – companies can and do go bankrupt. But if you pick the right business to buy shares in, you can make more than you can lose. Take, for example ProQR Therapeutics N.V. (NASDAQ:PRQR). Its share price is already up an impressive 231% in the last twelve months. And in the last month, the share price has gained 150%. In contrast, the longer term returns are negative, since the share price is 42% lower than it was three years ago.
Since the stock has added US$203m to its market cap in the past week alone, let’s see if underlying performance has been driving long-term returns.
See our latest analysis for ProQR Therapeutics
ProQR Therapeutics isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Shareholders of unprofitable companies usually desire strong revenue growth. Some companies are willing to postpone profitability to…
